OpenAI CEO Sam Altman confirmed interest in acquiring Google Chrome, as the US government mandates its sale. This follows a ...

The company, which has been referred to as Merge Labs, is looking at an approach involving gene therapy that would modify ...

At a dinner with reporters in San Francisco, OpenAI CEO Sam Altman spilled details on the company's ambitions beyond ChatGPT.

OpenAI's CEO is reportedly raising funds for a brain implant startup that would directly compete with Elon Musk's Neuralink.

Microsoft (MSFT)-backed OpenAI's latest venture, Merge Labs, is looking to develop a novel gene therapy approach targeting brain cells. Read more here.

After Musk said that 'Apple is behaving in a manner that makes it impossible for any AI company besides OpenAI to reach #1 in ...

Sam Altman plans to support a brain computer interface startup to rival Neuralink, as OpenAI expands its AI and technology ...

The big fast-food chains are rolling out often-elaborate drink offerings, hoping to increase margins and capture more sales ...

OpenAI CEO Sam Altman is reportedly working to launch a new brain-to-computer interface company, Merge Labs, with early ...

Sam Altman sees OpenAI eventually investing "trillions" in the infrastructure necessary to power artificial intelligence, but ...

The U.S. economy is in a strange place. Inflation is stubborn at 2.7%, job growth numbers have been revised down, trade barriers are up, investment sentiment is dropping in some quarters like the ...